Navigation Links
InterMune Announces Issuance of U.S. Patent for ITMN-191
Date:2/19/2009

BRISBANE, Calif., Feb. 19 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced the issuance of U.S. Patent Number 7,491,794, a composition of matter patent which covers the ITMN-191 (R7227) compound. The nominal 20-year patent term extends to October 13, 2024. ITMN-191 is an inhibitor of the hepatitis C virus (HCV) NS3/4A protease.

Dan Welch, Chairman, Chief Executive Officer and President of InterMune, said, "We are pleased to announce that this new patent, which is the foundation of our intellectual property coverage of ITMN-191, has issued. We look forward to continued progress in developing ITMN-191 with our partner, Roche, as we anticipate the start of our Phase 2b program in the second quarter of 2009."

About ITMN-191 (R7227)

ITMN-191 is being developed with InterMune's collaborative partner, Roche, for the treatment of patients chronically infected with HCV. On January 12, 2009, InterMune announced top-line results from a 14-day study of ITMN-191 in combination with Pegasys(R) (peginterferon alfa-2a) and Copegus(R) (ribavirin). InterMune reported that after 14 days of triple combination therapy, the median change in HCV RNA from baseline exceeded 5 log10 in five of the six dosage cohorts in the study, and was -5.4 log10 and -5.7 log10 in the best performing q12h and q8h cohorts, respectively. Reductions in HCV RNA occurred rapidly and there was no evidence of viral rebound during ITMN-191 treatment in any cohort. ITMN-191 was generally safe and well tolerated in the study. There were no serious adverse events or Grade 4 adverse events (AEs) during treatment with ITMN-191. AEs reported during study treatment (ITMN-191 or placebo) were predominantly mild to moderate in severity, typically consistent with the AE profile of standard of care (SOC), and none led to trea
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
2. InterMune Announces Proposed Public Offering of Common Stock
3. InterMune Announces Pricing of $68 Million Public Offering of Common Stock
4. InterMune Announces Closing of Public Offering of Common Stock
5. InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance
6. InterMune to Present at the SIGnificant Options in Healthcare Conference
7. Evotec Expands Collaboration With InterMune
8. Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
9. InterMune to Present at Deutsche Bank Health Care Conference
10. InterMune to Present at Bank of America Health Care Conference
11. InterMune to Present at Citigroup Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... 15 Aethlon Medical, Inc. (OTC Bulletin ... Schorey and Dr. Wayne Comper have ... Inc. (ESI). Both Dr. Schorey and Dr. Comper ... a wholly owned subsidiary of Aethlon Medical, was ... Hemopurifier®, a medical device being advanced as an ...
(Date:12/15/2009)... BRIARCLIFF MANOR, N.Y., Dec. 15 The ... announced that the professional society is continuing to ... is being held in Arlington, VA, April 19-21, ... society is encouraging non-members to join the organization ... event. The submission deadline is 12 AM EST, ...
(Date:12/15/2009)... , - ... the Ability of,Cardiopoietic Cells to Restore Cardiac Function ... leading Belgian biotechnology company specialising,in cell-based therapies for ... has completed, two months ahead of schedule,enrolment in ... trial of C-Cure, a,unique stem cell therapy for ...
(Date:12/14/2009)... Dyadic International, Inc. (Pink Sheets: DYAI) ("Dyadic") announced ... The Scripps Research Institute ("Scripps") by entering into ... of Dyadic,s patented and proprietary C1 fungus ("C1"). ... successful relationship between the two organizations which began ... annotate the C1 genome for the first time. ...
Breaking Biology Technology:Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 2Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 4Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 5The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 2The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 3Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5
... and Reliable DNA Extraction That Generates DNA Templates ... Tails Using prepGEM(TM) Yielded Over 34 Times the ... Extraction Kits -- SOLANA BEACH, Calif. and HAMILTON, ... a provider of innovative enzyme-based products for DNA ...
... Medical, Inc. (Nasdaq: ATSI ), manufacturer and ... announced participation in the upcoming 89th Annual Meeting of ... in Boston from May 10-13, 2009. The Annual ... and allied health professionals from around the world that ...
... Ltd. (SIX:,ARPN) will today discuss potential strategic scenarios with ... at 10am CET in Reinach,Switzerland. , ... Arpida has,initiated a thorough analysis with the aim to ... international experts in this field. , ...
Other Biology Technology:ZyGEM Releases Application Note Showing its DNA Extraction Kits Rapidly Produce High Yields of Quality DNA 2ZyGEM Releases Application Note Showing its DNA Extraction Kits Rapidly Produce High Yields of Quality DNA 3ZyGEM Releases Application Note Showing its DNA Extraction Kits Rapidly Produce High Yields of Quality DNA 4ATS Medical Announces Participation in the Annual Meeting of the American Association for Thoracic Surgeons 2ATS Medical Announces Participation in the Annual Meeting of the American Association for Thoracic Surgeons 3ATS Medical Announces Participation in the Annual Meeting of the American Association for Thoracic Surgeons 4Arpida to Discuss Strategy With Shareholders 2
(Date:12/14/2009)... A team of researchers from the Astrobiology Centre (INTA-CSIC) ... considered essential to the formation of the most basic ... blue. In order to carry out this study, published ... scientists recreated the chemical conditions of the early Earth. ... dissolved in ammoniac solutions it produces hydrogen cyanide, a ...
(Date:12/13/2009)... help to engineer plants that take advantage of elevated ... could help to engineer crops that take advantage of ... dioxide they need for photosynthesis through microscopic breathing pores ... of the gas gained, they lose hundreds of water ... to save water when CO 2 is abundant, ...
(Date:12/11/2009)... with the global "green" trend, educators worldwide ... to enhance students, science knowledge. Studies have ... curriculum raises not just science scoresenvironmental-based lessons ... other subject areas. Naturally, educators are interested ... relevant lessons into the classroom in hopes ...
Breaking Biology News(10 mins):Prussian blue linked to the origin of life 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3Students learn environmental stewardship, improve science scores 2ChildCare Education Institute Gives Child Care Staff a Professional Development Course in Observance of National Infant Mortality Awareness Month 56027 1ChildCare Education Institute Gives Child Care Staff a Professional Development Course in Observance of National Infant Mortality Awareness Month 56027 2A Mediterranean Approach to Flavorful Living 56023 1A Mediterranean Approach to Flavorful Living 56023 2A Mediterranean Approach to Flavorful Living 56023 3Resident Duty Hour Reform Associated With Increased Complication Rate 56018 1Resident Duty Hour Reform Associated With Increased Complication Rate 56018 2Resident Duty Hour Reform Associated With Increased Complication Rate 56018 3
... the Vaccine and Gene Therapy Institute (VGTI) at Oregon ... to better detect future monkeypox or smallpox outbreaks. The ... outbreak in the Midwest -- monkeypox is closely related ... outbreak was larger than the 72 cases reported by ...
... Scientists have used a glowing protein from fireflies to ... important target for new drugs to treat cancer, autoimmune ... known as IKK (for IKappa kinase), regulates processes that ... linked these changes to many different disorders. , "Our ...
... team of researchers has obtained data that help clarify our ... cats that once roamed the prehistoric New World. , The ... Biology by Ross Barnett of the University of Oxford and ... and Australia. , Toward the end of the last Ice ...
Other Biology News:Researchers develop new testing methods for potential monkeypox or smallpox outbreak 2Researchers develop new testing methods for potential monkeypox or smallpox outbreak 3Firefly protein lets researchers monitor molecule linked to cancer 2Firefly protein lets researchers monitor molecule linked to cancer 3DNA traces evolution of extinct sabertooths and the American cheetah-like cat 2
Mouse monoclonal [3B6] to HSV1 + HSV2 ICP5 Major Capsid Protein ( Abpromise for all tested applications)....
Phosphotyrosine IgG mouse monoclonal antibody: Alkaline Phosphatase conjugate...
Rabbit polyclonal to GPCR G2A ( Abpromise for all tested applications). entrezGeneID: 29933 SwissProtID: Q9UNW8...
... reagent has been developed for use ... reduction of nonspecific background staining due ... describe blocking peroxidase with hydrogen peroxide. ... in combination with additional novel components ...
Biology Products: